Is there a correlation between serum antifungal drug concentration and clinical outcome?
- 31 May 1994
- journal article
- research article
- Published by Elsevier in Journal of Infection
- Vol. 28, 17-24
- https://doi.org/10.1016/s0163-4453(94)95926-9
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- Effectiveness of an Oral Triazole for Opportunistic Mold Infections in Patients with Cancer: Experience with SCH 39304Clinical Infectious Diseases, 1993
- Treatment of cryptococcosis with liposomal amphotericin B (AmBisome) in 23 patients with AIDSAIDS, 1993
- Itraconazole, fluconazole, and amphotericin B in antifungal therapyCurrent Opinion in Infectious Diseases, 1991
- Comparative Safety, Tolerance, and Pharmacokinetics of Amphotericin B Lipid Complex and Amphotericin B Desoxycholate in Healthy Male VolunteersThe Journal of Infectious Diseases, 1991
- Laboratory monitoring of antifungal chemotherapyThe Lancet, 1991
- Itraconazole therapy for nonmeningeal coccidioidomycosis: Clinical and laboratory observationsJournal of the American Academy of Dermatology, 1990
- Antifungal Prophylaxis with Itraconazole in Prolonged Neutropenia: Correlation with Plasma LevelsMycoses, 1989
- ItraconazoleDrugs, 1989
- Clinical Pharmacokinetics of KetoconazoleClinical Pharmacokinetics, 1988
- Amphotericin B in the Treatment of CoccidioidomycosisDrugs, 1983